Riskpilot← Back to searchSign inGet full accessThern Medicine AB
ABActiveOrg 5590138771Storgårdsvägen 15Medical specialists activities · NACE 8622Est. 20151-4 employees
Revenue 2024
SEK 1,3M
-29% vs 2023
EBITDA margin
-23.6%
-389% vs 2023
Equity ratio
-0.8%
Financial strength
Net profit 2024
SEK -10K
-109% vs 2023
| Revenue | SEK 1,3M | -29% |
| EBITDA | SEK -299K | -389% |
| Net profit | SEK -10K | -109% |
| Total assets | SEK 408K | -22% |
| Equity | SEK -3K | -149% |
| Employees | — | — |
Legal name
Thern Medicine AB
Org number
5590138771
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 maj 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom medicinska behandlingar via hembesök, på kliniker och hemma. Konsultverksamhet som läkare till landsting och privata kliniker. Läkarledda medicinska bedömningar, rådgivning och behandlingar inom området håravfall och tunnhårighet. Vidare utbildning och kursverksamhet samt försäljning av hårprodukter och skönhetsprodukter inom samma område samt därmed förenlig verksamhet.Fotograf och därmed förenlig verksamhet.
Address
Storgårdsvägen 15
Email
patricia.thern@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 461 | 249 | 1 285 | 1 774 | 1 264 |
| Staff expenses | — | — | −639 | −1 233 | −1 022 |
| EBITDA | −255 | −86 | 244 | 104 | −299 |
| Depreciation & amort. | −0 | −0 | −11 | −11 | −11 |
| EBIT | −255 | −86 | 233 | 93 | −309 |
| Net financials | 149 | — | −23 | 43 | 299 |
| Profit before tax | −107 | −87 | 210 | 136 | −10 |
| Tax | 2 | −0 | — | −15 | — |
| Net profit | −105 | −87 | 210 | 121 | −10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 101 | 111 | 432 | 525 | 408 |
| Equity | −47 | −134 | 77 | 7 | −3 |
| Long-term debt | 2 | 119 | 0 | — | — |
| Short-term debt | 146 | 126 | 356 | 518 | 411 |
| Total debt | 148 | 245 | 356 | 518 | 411 |
EBITDA margin
-23.6%
This company
15.8%
Market median
-249% vs market
20202024
Equity ratio
-0.8%
This company
38.2%
Market median
-102% vs market
20202024
Return on equity
-1046400.0%
This company
18.4%
Market median
-5687057% vs market
20202024
Net profit margin
-0.8%
This company
8.1%
Market median
-110% vs market
20202024
Asset turnover
3.10×
This company
1.12×
Market median
+177% vs market
20202024
Debt / equity
119.38×
This company
0.62×
Market median
-19155% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Thern Medicine AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Erik Thern | Board of Directors | 0 companies |
| Monica Charlotta Jonsson | Deputy Board Member | 0 companies |
| Patricia Izabell Thern | Chairman | 0 companies |